The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Antifungal resistance: current trends and future strategies to combat
Open accessAbstract
Antifungal resistance represents a major clinical challenge to clinicians responsible for treating invasive fungal infections due to the limited arsenal of systemically available antifungal agents. In addition current drugs may be limited by drug–drug interactions and serious adverse effects/toxicities that prevent their prolonged use or dosage escalation. Fluconazole resistance is of particular concern in non- Candida albicans species due to the increased incidence of infections caused by these species in different geographic locations worldwide and the elevated prevalence of resistance to this commonly used azole in many institutions. C. glabrata resistance to the echinocandins has also been documented to be rising in several US institutions, and a higher percentage of these isolates may also be azole resistant. Azole resistance in Aspergillus fumigatus due to clinical and environmental exposure to this class of agents has also been found worldwide, and these isolates can cause invasive infections with high mortality rates. In addition, several species of Aspergillus , and other molds, including Scedosporium and Fusarium species, have reduced susceptibility or pan-resistance to clinically available antifungals. Various investigational antifungals are currently in preclinical or clinical development, including several of them that have the potential to overcome resistance observed against the azoles and the echinocandins. These include agents that also target ergosterol and β-glucan biosynthesis, as well as compounds with novel mechanisms of action that may also overcome the limitations of currently available antifungal classes, including both resistance and adverse effects/toxicity. Keywords: azoles, echinocandins, Aspergillus , Candida albicans , investigational antifungals, non- albicans Candida species, acquired resistance, intrinsic resistance, Candida auris
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Infections Caused by Scedosporium spp
Cortez, K. J., Roilides, E., Quiroz-Telles, F., Meletiadis, J., Antachopoulos, C., Knudsen, T., Buchanan, W., Milanovich, J., Sutton, D. A., Fothergill, A., et al. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00039-07 · Cited by 786
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778
Cornely, O. A., Maertens, J., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heussel, C. P., Lortholary, O., Rieger, C., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 751
Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Epidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610
Infections due to emerging and uncommon medically important fungal pathogens
Walsh, T. J., Groll, A., Hiemenz, J., Fleming, R., Roilides, E., & Anaissie, E. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00839.x · Cited by 601
Verweij, P. E., Chowdhary, A., Melchers, W. J. G., & Meis, J. F. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ885 · Cited by 561
Kathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 532
Candida albicans Cell Wall Proteins
Chaffin, W. L. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00032-07 · Cited by 515
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454
Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
Snelders, E., Huis in 't Veld, R. A. G., Rijs, A. J. M. M., Kema, G. H. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00231-09 · Cited by 423
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 416
Husain, S., Munoz, P., Forrest, G., Alexander, B. D., Somani, J., Brennan, K., Wagener, M. M., & Singh, N. (2005) · Clinical Infectious Diseases · doi:10.1086/426445 · Cited by 401
Larkin, E., Hager, C., Chandra, J., Mukherjee, P. K., Retuerto, M., Salem, I., Long, L., Isham, N., Kovanda, L., Borroto-Esoda, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02396-16 · Cited by 395
Multiple-Triazole–Resistant Aspergillosis
Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit320 · Cited by 342
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
Bueid, A., Howard, S. J., Moore, C. B., Richardson, M. D., Harrison, E., Bowyer, P., & Denning, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq279 · Cited by 338
O'Donnell, K., Sarver, B. A. J., Brandt, M., Chang, D. C., Noble-Wang, J., Park, B. J., Sutton, D. A., Benjamin, L., Lindsley, M., Padhye, A., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00533-07 · Cited by 336
Fusarium Infection in Hematopoietic Stem Cell Transplant Recipients
Nucci, M., Marr, K. A., Queiroz-Telles, F., Martins, C. A., Trabasso, P., Costa, S., Voltarelli, J. C., Colombo, A. L., Imhof, A., Pasquini, R., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/383319 · Cited by 333
Garcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-08 · Cited by 323
Garcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323
Aspergillus species identification in the clinical setting
Balajee, S. A., Houbraken, J., Verweij, P. E., Hong, S.-B., Yaghuchi, T., Varga, J., & Samson, R. A. (2007) · Studies in Mycology · doi:10.3114/sim.2007.59.05 · Cited by 302
Balajee, S. A., Kano, R., Baddley, J. W., Moser, S. A., Marr, K. A., Alexander, B. D., Andes, D., Kontoyiannis, D. P., Perrone, G., Peterson, S., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01070-09 · Cited by 302
Echinocandin resistance: an emerging clinical problem?
Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299
Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*
Guarro, J., Kantarcioglu, A. S., Horré, R., Luis Rodriguez-Tudela, J., Cuenca Estrella, M., Berenguer, J., & Sybren De Hoog, G. (2006) · Medical Mycology · doi:10.1080/13693780600752507 · Cited by 297
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase
Oliver, J. D., Sibley, G. E. M., Beckmann, N., Dobb, K. S., Slater, M. J., McEntee, L., du Pré, S., Livermore, J., Bromley, M. J., Wiederhold, N. P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608304113 · Cited by 289
Self-citationHealey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276
Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)
Alastruey-Izquierdo, A., Mellado, E., Peláez, T., Pemán, J., Zapico, S., Alvarez, M., Rodríguez-Tudela, J. L., Cuenca-Estrella, M., & FILPOP Study Group (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00383-13 · Cited by 276
Pfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274
Lockhart, S. R., Frade, J. P., Etienne, K. A., Pfaller, M. A., Diekema, D. J., & Balajee, S. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-11 · Cited by 231
Sharma, C., Kumar, N., Pandey, R., Meis, J. F., & Chowdhary, A. (2016) · New Microbes and New Infections · doi:10.1016/j.nmni.2016.07.003 · Cited by 202
In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
Miyazaki, M., Horii, T., Hata, K., Watanabe, N.-A., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., Inoue, S., Matsukura, M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00291-11 · Cited by 200
Improvement in the outcome of invasive fusariosis in the last decade
Nucci, M., Marr, K. A., Vehreschild, M. J. G. T., de Souza, C. A., Velasco, E., Cappellano, P., Carlesse, F., Queiroz-Telles, F., Sheppard, D. C., Kindo, A., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12409 · Cited by 197
Design and optimization of highly-selective fungal CYP51 inhibitors
Hoekstra, W. J., Garvey, E. P., Moore, W. R., Rafferty, S. W., Yates, C. M., & Schotzinger, R. J. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.068 · Cited by 192
Vallabhaneni, S., Cleveland, A. A., Farley, M. M., Harrison, L. H., Schaffner, W., Beldavs, Z. G., Derado, G., Pham, C. D., Lockhart, S. R., & Smith, R. M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv163 · Cited by 187
Candida glabrata Fungemia: Experience in a Tertiary Care Center
Malani, A., Hmoud, J., Chiu, L., Carver, P. L., Bielaczyc, A., & Kauffman, C. A. (2005) · Clinical Infectious Diseases · doi:10.1086/432939 · Cited by 184
Proposed nomenclature for Pseudallescheria, Scedosporium and related genera
Lackner, M., de Hoog, G. S., Yang, L., Ferreira Moreno, L., Ahmed, S. A., Andreas, F., Kaltseis, J., Nagl, M., Lass-Flörl, C., Risslegger, B., et al. (2014) · Fungal Diversity · doi:10.1007/s13225-014-0295-4 · Cited by 180
FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
Beyda, N. D., John, J., Kilic, A., Alam, M. J., Lasco, T. M., & Garey, K. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu407 · Cited by 174
Warrilow, A. G. S., Hull, C. M., Parker, J. E., Garvey, E. P., Hoekstra, W. J., Moore, W. R., Schotzinger, R. J., Kelly, D. E., & Kelly, S. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03707-14 · Cited by 173
Shields, R. K., Nguyen, M. H., Press, E. G., Kwa, A. L., Cheng, S., Du, C., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-12 · Cited by 171
Scedosporium Infection in a Tertiary Care Cancer Center: A Review of 25 Cases from 1989-2006
Lamaris, G. A., Chamilos, G., Lewis, R. E., Safdar, A., Raad, I. I., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/509579 · Cited by 163
Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults
Sandison, T., Ong, V., Lee, J., & Thye, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01627-16 · Cited by 161
Thompson, G. R., Wiederhold, N. P., Vallor, A. C., Villareal, N. C., Lewis, J. S., & Patterson, T. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00473-08 · Cited by 160
Self-citationEmerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients
Nucci, M. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200312000-00015 · Cited by 153
Hata, K., Horii, T., Miyazaki, M., Watanabe, N.-A., Okubo, M., Sonoda, J., Nakamoto, K., Tanaka, K., Shirotori, S., Murai, N., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00366-11 · Cited by 149
Triazole Resistance in Aspergillus spp.: A Worldwide Problem?
Rivero-Menendez, O., Alastruey-Izquierdo, A., Mellado, E., & Cuenca-Estrella, M. (2016) · Journal of Fungi · doi:10.3390/jof2030021 · Cited by 142
Xiao, M., Fan, X., Chen, S. C. ‐., Wang, H., Sun, Z., Liao, K., Chen, S.-L., Yan, Y., Kang, M., Hu, Z.-D., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku460 · Cited by 141
Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania
Chowdhary, A., Sharma, C., van den Boom, M., Yntema, J. B., Hagen, F., Verweij, P. E., & Meis, J. F. G. M. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku259 · Cited by 137
Mistaken Identity: Neosartorya pseudofischeri and Its Anamorph Masquerading as Aspergillus fumigatus
Balajee, S. A., Gribskov, J. L., Brandt, M. E., Ito, J. I., Fothergill, A. W., & Marr, K. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.12.5996-5999.2005 · Cited by 134
Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin
Ong, V. S., Hough, G., Schlosser, M., Bartizal, K. F., Balkovec, J. M., James, K. D., & Krishnan, B. R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00701-16 · Cited by 133
Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India
Chowdhary, A., Sharma, C., Kathuria, S., Hagen, F., & Meis, J. F. G. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt397 · Cited by 132
Lewis, R. E., Wiederhold, N. P., & Klepser, M. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.945-951.2005 · Cited by 129
Self-citationVarga, J., Houbraken, J. A. M. P., van der Lee, H. A. L., Verweij, P. E., & Samson, R. A. (2008) · Eukaryotic Cell · doi:10.1128/ec.00425-07 · Cited by 128
Arendrup, M. C., Perlin, D. S., Jensen, R. H., Howard, S. J., Goodwin, J., & Hope, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06369-11 · Cited by 117
In Vitro and In Vivo Antifungal Activities of T-2307, a Novel Arylamidine
Mitsuyama, J., Nomura, N., Hashimoto, K., Yamada, E., Nishikawa, H., Kaeriyama, M., Kimura, A., Todo, Y., & Narita, H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01159-07 · Cited by 111
Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Jones, R. N., & Castanheira, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw214 · Cited by 111
Oberoi, J. K., Wattal, C., Goel, N., Raveendran, R., Datta, S., & Prasad, K. (2012) · PubMed Central · Cited by 110
Epidemiology of Invasive Mold Infections in Lung Transplant Recipients
Doligalski, C. T., Benedict, K., Cleveland, A. A., Park, B., Derado, G., Pappas, P. G., Baddley, J. W., Zaas, D., Harris, M., & Alexander, B. D. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12691 · Cited by 109
Berkow, E. L., Angulo, D. A., & Lockhart, S. R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00435-17 · Cited by 109
Lepak, A. J., Marchillo, K., & Andes, D. R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04445-14 · Cited by 103
Lamoth, F., & Alexander, B. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00234-15 · Cited by 100
Pfaller, M. A., Messer, S. A., Motyl, M. R., Jones, R. N., & Castanheira, M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks466 · Cited by 100
T-2307 Causes Collapse of Mitochondrial Membrane Potential in Yeast
Shibata, T., Takahashi, T., Yamada, E., Kimura, A., Nishikawa, H., Hayakawa, H., Nomura, N., & Mitsuyama, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05954-11 · Cited by 99
Castanheira, M., Duncanson, F. P., Diekema, D. J., Guarro, J., Jones, R. N., & Pfaller, M. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05414-11 · Cited by 98 · cited 1×
“100 103 This in vitro activity has also translated into efficacy in animal models of invasive fungal infections, including invasive candidiasis caused by azole-and echinocandin-resistant isolates, aspergillosis, and fusariosis.”
Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida spp
Messer, S. A., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J., & Pfaller, M. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.324-326.2006 · Cited by 97
In Vitro and In Vivo Antimalarial Activities of T-2307, a Novel Arylamidine
Kimura, A., Nishikawa, H., Nomura, N., Mitsuyama, J., Fukumoto, S., Inoue, N., & Kawazu, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05856-11 · Cited by 96
Invasive candidiasis in intensive care units in China: a multicentre prospective observational study
Guo, F., Yang, Y., Kang, Y., Zang, B., Cui, W., Qin, B., Qin, Y., Fang, Q., Qin, T., Jiang, D., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt083 · Cited by 93
Wiederhold, N. P., Law, D., & Birch, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx065 · Cited by 89
Self-citationSugui, J. A., Peterson, S. W., Abigail, F., Hansen, B. T., Samson, R. A., Mellado, E., Cuenca‐Estrella, M., & Kwon-Chung, K. J. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01704-14 · Cited by 86
Susceptibility and Diversity in the Therapy-Refractory Genus Scedosporium
Lackner, M., Hagen, F., Meis, J. F. G. M., van den Ende, A. H. G. G., Vu, D., Robert, V., Fritz, J., Moussa, T. A. A., & de Hoog, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03211-14 · Cited by 86
ASP2397: a novel antifungal agent produced by Acremonium persicinum MF-347833
Nakamura, I., Yoshimura, S., Masaki, T., Takase, S., Ohsumi, K., Hashimoto, M., Furukawa, S., & Fujie, A. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.107 · Cited by 85
Garvey, E. P., HOEKSTRA, W., Schotzinger, R. J., Sobel, J. D., Lilly, E. A., & Fidel, P. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-15 · Cited by 84
CD101: a novel long-acting echinocandin
Zhao, Y., Perez, W. B., Jiménez‐Ortigosa, C., Hough, G., Locke, J. B., Ong, V., Bartizal, K., & Perlin, D. S. (2016) · Cellular Microbiology · doi:10.1111/cmi.12640 · Cited by 81
Nakamura, I., Kanasaki, R., Yoshikawa, K., Furukawa, S., Fujie, A., Hamamoto, H., & Sekimizu, K. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.106 · Cited by 78
Pfaller, M. A., Duncanson, F. P., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00570-11 · Cited by 76
Biswas, C., Sorrell, T. C., Djordjevic, J. T., Zuo, X., Jolliffe, K. A., & Chen, S. C. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt282 · Cited by 75
Warrilow, A. G. S., Parker, J. E., Price, C. L., Nes, W. D., Garvey, E. P., Hoekstra, W. J., Schotzinger, R. J., Kelly, D. E., & Kelly, S. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-16 · Cited by 75
Hargrove, T. Y., Garvey, E. P., Hoekstra, W. J., Yates, C. M., Wawrzak, Z., Rachakonda, G., Villalta, F., & Lepesheva, G. I. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00570-17 · Cited by 75
Wiederhold, N. P., Patterson, H. P., Tran, B. H., Yates, C. M., Schotzinger, R. J., & Garvey, E. P. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx410 · Cited by 75
Self-citationLocke, J. B., Almaguer, A. L., Zuill, D. E., & Bartizal, K. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00620-16 · Cited by 70
Adhikary, R., & Joshi, S. (2011) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.83920 · Cited by 68
Johnson, L. S., Shields, R. K., & Clancy, C. J. (2014) · Transplant Infectious Disease · doi:10.1111/tid.12244 · Cited by 67
Lockhart, S. R., Fothergill, A. W., Iqbal, N., Bolden, C. B., Grossman, N. T., Garvey, E. P., Brand, S. R., Hoekstra, W. J., Schotzinger, R. J., Ottinger, E., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02770-15 · Cited by 67
Self-citationPfaller, M. A., Hata, K., Jones, R. N., Messer, S. A., Moet, G. J., & Castanheira, M. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.05.001 · Cited by 60
Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-13 · Cited by 56
Wiederhold, N. P., Najvar, L. K., Fothergill, A. W., McCarthy, D. I., Bocanegra, R. A., Olivo, M., Kirkpatrick, W. R., Everson, M. P., Duncanson, F. P., & Patterson, T. F. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03944-14 · Cited by 56
Self-citationEvaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models
Shubitz, L. F., Trinh, H. T., Galgiani, J. N., Lewis, M. L., Fothergill, A. W., Wiederhold, N. P., Barker, B. M., Lewis, E. R. G., Doyle, A., Hoekstra, W. J., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00593-15 · Cited by 56
Self-citationWiederhold, N. P., Najvar, L. K., Fothergill, A. W., Bocanegra, R., Olivo, M., McCarthy, D. I., Fukuda, Y., Mitsuyama, J., & Patterson, T. F. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv398 · Cited by 48
Self-citationUptake of T-2307, a novel arylamidine, in Candida albicans
Nishikawa, H., Yamada, E., Shibata, T., Uchihashi, S., Fan, H., Hayakawa, H., Nomura, N., & Mitsuyama, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq177 · Cited by 46
Pfaller, M. A., Castanheira, M., Messer, S. A., & Jones, R. N. (2015) · Mycoses · doi:10.1111/myc.12299 · Cited by 43
Wiederhold, N. P., Najvar, L. K., Fothergill, A. W., Bocanegra, R., Olivo, M., McCarthy, D. I., Kirkpatrick, W. R., Fukuda, Y., Mitsuyama, J., & Patterson, T. F. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04228-14 · Cited by 36 · cited 1×
“glabrata,(109,110) and in vivo efficacy has also been demonstrated in the in vivo models of infections caused by resistant isolates.(106,109,110) In vitro activity and in vivo efficacy have also been reported against Cryptococcus and Aspergillus species.”
BackgroundSelf-citationGhebremedhin, B., Bluemel, A., Neumann, K. H., Koenig, B., & Köenig, W. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.005785-0 · Cited by 32
Liao, X., Qiu, H., Li, R., Guo, F., Liu, W. Y., Kang, M., & Kang, Y. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.04.002 · Cited by 28
Population-Based Survey of Filamentous Fungi and Antifungal Resistance in Spain (FILPOP Study)
Alastruey‐Izquierdo, A., Mellado, E., Peláez, T., Pemán, J., Zapico, S., Álvarez, M. V., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01287-13 · Cited by 27
Cited by
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Candida albicans—The Virulence Factors and Clinical Manifestations of Infection
Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021) · Journal of Fungi · doi:10.3390/jof7020079 · Cited by 794
“However, it should be borne in mind that antifungal prophylaxis may favor resistance development [163].”
BackgroundAntifungal drug resistance: evolution, mechanisms and impact
Revie, N. M., Iyer, K. R., Robbins, N., & Cowen, L. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.02.005 · Cited by 516
Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
Carolus, H., Pierson, S., Lagrou, K., & Van Dijck, P. (2020) · Journal of Fungi · doi:10.3390/jof6040321 · Cited by 349
Encapsulation of essential oils and their application in antimicrobial active packaging
Mukurumbira, A. R., Shellie, R. A., Keast, R., Palombo, E. A., & Jadhav, S. R. (2022) · Food Control · doi:10.1016/j.foodcont.2022.108883 · Cited by 270
Metadata
- Authors
- Wiederhold, N.
- Venue
- Infection and Drug Resistance
- Publisher
- Informa UK Limited
- Published
- 2017-08
- Volume
- Volume 10
- Pages
- 249-259
- ISSN
- 1178-6973 (ISSN-L)
- OpenAlex
- W2753619282
- Cited by
- 468
- References
- 102
- FWCI
- 31.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.